Association study of the gamma-aminobutyric acid type a receptor γ2 subunit gene with schizophrenia

Schizophrenia Research

Volumn 114, Issue 1-3, 2009, Pages 33-38

  Zai, Clement C ^a,b   Tiwari, Arun K ^a   King, Nicole ^a   De Luca, Vincenzo ^a,c   Mueller, Daniel J ^a,c   Shaikh, Sajid ^a   Wong, Greg W H ^a   Meltzer, Herbert Y ^d   Lieberman, Jeffrey A ^e   Kennedy, James L ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d VANDERBILT UNIVERSITY   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Dopamine receptor gene DRD5; Family based association test; GABAA gamma2 subunit gene GABRG2; Genetics; Haplotype analysis; Paired case control sample; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA 2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; NUCLEAR FAMILY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GABA-A; SCHIZOPHRENIA; YOUNG ADULT;

EID: 69849108231     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.07.010     Document Type: Article

References (45)

1. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., and Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 40 7 (2008) 827-834
2. Ambrosio A.M., Kennedy J.L., Macciardi F., King N., Azevedo M.H., Oliveira C.R., and Pato C.N. A linkage study between the GABAA beta2 and GABAA gamma2 subunit genes and major psychoses. CNS Spectrum. 10 1 (2005) 57-61
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. (1994), American Psychiatric Association, Washington, DC
4. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
5. Benes F.M., Vincent S.L., Alsterberg G., Bird E.D., and SanGiovanni J.P. Increased GABAA receptor binding in superficial layers of cingulated cortex in schizophrenics. J. Neurosci. 12 3 (1992) 924-929
6. Dean B., Hussain T., Hayes W., Scarr E., Kitsoulis S., Hill C., Opeskin K., and Copolov D.L. Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. J. Neurochem. 72 4 (1999) 1593-1599
7. Delini-Stula A., and Berdah-Tordjman D. Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia-a study group report. J. Psychiatry Res. 30 4 (1996) 239-250
8. First M.B., Spitzer R.L., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I and II Disorders (1997), American Psychiatric Press, Washington, DC
9. Goldman-Rakic P.S., and Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizo. Bull. 23 (1997) 437-458
10. Guidotti A., Auta J., Davis J.M., Dong E., Grayson D.R., Veldic M., Zhang M., and Costa E. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacol. (Berl. 180 2 (2005) 191-205
11. Hedges L.V., and Olkin I. Tests of statistical significance of combined results. In: Statistical methods for meta-analysis (1985), Academic Press, Orlando 27-46
12. Hicks A.A., Bailey M.E., Riley B.P., Kamphuis W., Siciliano M.J., Johnson K.J., and Darlison M.G. Further evidence for clustering of human GABAA receptor subunit genes: localization of the alpha6-subunit gene (GABRA6) to distal chromosome 5q by linkage analysis. Genomics 20 2 (1994) 285-288
13. Hodgkinson C.A., Xu K., Yuan Y.-P., Shen P.-H., Heinz E., Lobos E.A., Binder E.B., Cubells J., Ehlers C.L., Gelernter J., Mann J., Riley B., Roy A., Tabakoff B., Todd R.D., Zhou Z., and Goldman D. Addictions biology: haplotype based analysis for 130 candidate genes on a single array. Alcohol. Alcohol. 43 5 (2008) 505-515
14. Hoogendoorn M.L., Bakker S.C., Schnack H.G., Selten J.P., Otten H.G., Verduijn W., van der Heijden F.M., Pearson P.L., Kahn R.S., and Sinke R.J. No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. Am. J. Med. Genet. 134B 1 (2005) 6-9
15. Hovarth S., Xu X., and Laird N.M. The family based association test method: strategies for studying general genotype-phenotype associations. Eur. J. Hum. Genet. 9 (2001) 304-306
16. Huntsman M.M., Tran B.-V., Potkin S.G., Bunney Jr. W.E., and Jones E.G. Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics. P.N.A.S. 95 (1998) 15066-15071
17. A receptor cluster in Japanese schizophrenia patients. Biol. Psychiatry. 58 (2005) 440-445
18. Johnson K.J., Sander T., Hicks A.A., van Marle A., Janz D., Mullan M.J., Riley B.P., and Darlison M.G. Confirmation of the localization of the human GABAA receptor alpha1-subunit gene (GABRA1) to distal 5q by linkage analysis. Genomics 14 3 (1992) 745-748
19. Knoflach F., Rhyner T., Villa M., Kellenberger S., Drescher U., Malherbe P., Sigel E., and Mohler H. The gamma 3-subunit of the GABAA-receptor confers sensitivity to benzodiazepine receptor ligands. FEBS Lett 293 1-2 (1991) 191-194
20. Lahiri D.K., and Nurnburger Jr. J.I. A rapid non-enzymatic method for the preparation of HMV DNA from blood for RFLP analysis. Nuc. Acids Res. 19 (1991) 5444
21. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., Williams N.M., Schwab S.G., Pulver A.E., Faraone S.V., Brzustowicz L.M., Kaufmann C.A., Garver D.L., Gurling H.M., Lindholm E., Coon H., Moises H.W., Byerley W., Shaw S.H., Mesen A., Sherrington R., O'Neill F.A., Walsh D., Kendler K.S., Ekelund J., Paunio T., Lonnqvist J., Peltonen L., O'Donovan M.C., Owen M.J., Wildenauer D.B., Maier W., Nestadt G., Blouin J.L., Antonarakis S.E., Mowry B.J., Silverman J.M., Crowe R.R., Cloninger C.R., Tsuang M.T., Malaspina D., Harkavy-Friedman J.M., Svrakic D.M., Bassett A.S., Holcomb J., Kalsi G., McQuillin A., Brynjolfson J., Sigmundsson T., Petursson H., Jazin E., Zoega T., and Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet. 73 1 (2003) 34-48
22. Liu F., Wan Q., Pristupa Z.B., Yu X.-M., Wang Y.T., and Niznik H.B. Direct protein-protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors. Nature 403 (2000) 274-280
23. Lo W.-S., Lau C.-F., Xuan Z., Chan C.-F., Feng G.-Y., He L., Cao Z.-C., Liu H., Luan Q.-M., and Xue H. Association of SNPs and haplotypes in GABAA receptor b2 gene with schizophrenia. Molecular Psychiatry. 9 (2004) 603-608
24. Maxwell E. The Family Interview for Genetic Studies: Manual. Clinical Neurogenetics Branch, Intramural Research Program (1992), National Institute of Mental Health, Washington, DC. http://zork.wustl.edu/nimh/figs/figs_train.pdf http://zork.wustl.edu/nimh/figs/figs_train.pdf
25. McGuffin P. Nature and nurture interplay. Psychiatr Prax 31 S2 (2004) 189-193
26. Moore H., West A.R., and Grace A.A. The regulation of forebrain dopamine transmission. Biol Psychiat. 46 (1999) 40-55
27. Muir W.J., Thomson M.L., McKeon P., Mynett-Johnson L., Whitton C., Evans K.L., Porteous D.J., and Blackwood D.H. Markers close to the dopamine D5 receptor gene (DRD5) show significant association with schizophrenia but not bipolar disorder. Am J Med Genet 105 2 (2001) 152-158
28. A receptor γ2 subunit gene (GABRG2) and methamphetamine use disorder. Pharmacogenomics J. 5 (2005) 89-95
29. Okubo Y., Suhara T., Suzuki K., Kobayashi K., Inoue O., Terasaki O., Someya Y., Sassa T., Sudo Y., Matsushima E., Iyo M., Tateno Y., and Toru M. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385 (1997) 634-636
30. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 316 (1998) 1236-1238
31. A receptor subunit genes in schizophrenia. Mol. Psychiatry. 10 12 (2005) 1074-1088 1057
32. Purcell S., Cherny S.S., and Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 1 (2003) 149-150
33. Sklar P., Pato M.T., Kirby A., Petryshen T.L., Medeiros H., Carvalho C., Macedo A., Dourado A., Coelho I., Valente J., Soares M.J., Ferreira C.P., Lei M., Verner A., Hudson T.J., Morley C.P., Kennedy J.L., Azevedo M.H., Lander E., Daly M.J., and Pato C.N. Genome-wide scan in Portuguese Island families identifies 5q31-q35 as a susceptibility locus for schizophrenia and psychosis. Mol. Psychiatry. 9 2 (2004) 213-218
34. Sobell J.L., Lind T.J., Sigurdson D.C., Zald D.H., Snitz B.E., Grove W.H., Heston L.L., and Sommer S.S. The D5 dopamine receptor gene in schizophrenia: identification of a nonsense change and multiple missense changes but lack of association with disease. Hum. Mol. Genet. 4 4 (1995) 507-514
35. Statistical Package for the Social Sciences. SPSS for Windows, Rel. 10.0.7. Chicago (2000), SPSS Inc
36. Tanaka S. Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation. BMC Neurosci. 9 (2008) 41 10.1186/1471-2202-9-41
37. Turunen J.A., Paunio T., Ekelund J., Suhonen J., Varilo T., Partonen T., Jokiaho A., Hennah W., Parker A., Meyer J., Lönnqvist J., and Peltonen L. Am J Med Genet 122B 1 (2003) 18 (O4
38. Vestergaard M., Pedersen C.B., Christensen J., Madsen K.M., Olsen J., and Mortensen P.B. Febrile seizures and risk of schizophrenia. Schizophr. Res. 73 2-3 (2005) 343-349
39. Wafford K.A., Burnett D.M., Leidenheimer N.J., Burt D.R., Wang J.B., Kofuji P., Dunwiddie T.V., Harris R.A., and Sikela J.M. Ethanol sensitivity of the GABAA receptor expressed in Xenopus oocytes requires 8 amino acids contained in the gamma 2L subunit. Neuron 7 1 (1991) 27-33
40. A receptor γ2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28 (2001) 49-52
41. Wassef A.A., Dott S.G., Harris A., Brown A., O'Boyle M., Meyer III W.J., and Rose R.M. Critical review of GABA-ergic drugs in the treatment of schizophrenia. J. Clin. Psychopharmacol. 19 3 (1999) 222-232
42. Wilcox A.S., Warrington J.A., Gardiner K., Berger R., Whiting P., Altherr M.R., Wasmuth J.J., Patterson D., and Sikela J.M. Human chromosomal localization of genes encoding the gamma1 and gamma2 subunits of the gamma aminobutyric acid receptor indicates that members of this gene family are often clustered in the genome. P.N.A.S. 89 13 (1992) 5857-5861
43. Williams N.M., Cardno A.G., Murphy K.C., Jones L.A., Asherson P., McGuffin P., and Owen M.J. Association between schizophrenia and a microsatellite polymorphism at the dopamine D5 receptor gene. Psychiatr Genet 7 2 (1997) 83-85
44. A β2 and γ2 gene polymorphisms with event-related prefrontal activity in man. Hum. Genet. 107 (2000) 513-518
45. Zai C.C., Romano-Silva M.A., Hwang R.W., Zai G.C., de Luca V., Müller D.J., King N., Voineskos A.N., Meltzer H.Y., Lieberman J.A., Potkin S.G., Remington G., and Kennedy J.L. Genetic study of eight AKT1 Gene polymorphisms and their interaction with DRD2 Gene polymorphisms in tardive dyskinesia. Schizophr. Res. 106 2-3 (2008) 248-252